Gallant DR Implantable Cardioverter Defibrillator Bluetooth Malfunction Affects Remote Monitoring
St. Jude Medical's Gallant DR implantable cardioverter defibrillator has a Bluetooth malfunction preventing remote monitoring and reducing battery life. The device enters inductive-only telemetry mode, requiring in-clinic monitoring instead.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II recall affects a critical life-saving device with a functional defect that impairs remote monitoring capability. Loss of remote monitoring for an implantable cardioverter defibrillator constitutes a risk-of-harm situation, even though no illnesses or injuries have been reported.
Plain-English summary
St. Jude Medical, Cardiac Rhythm Management Division, is recalling the Gallant DR Implantable Cardioverter Defibrillator (REF# CDDRA500Q) due to a Bluetooth malfunction. The defect causes the device to enter an inductive-only telemetry mode, resulting in loss of Bluetooth communication capability.
The primary impact is the inability to remotely monitor these devices. Instead of remote communication, patients must visit their healthcare provider's clinic or office for device monitoring and checks.
Additionally, the Bluetooth malfunction results in reduced battery longevity in affected devices. No illnesses or injuries have been reported in connection with this defect.
Patients with an affected device should contact their healthcare provider to discuss monitoring options and any appropriate follow-up care.
The recalled product
- Product
- Gallant DR Implantable Cardioverter Defibrillator REF # CDDRA500Q
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- REF# CDDRA500Q SN# 111018237
- Exp Date: 31-Oct-2022 Material# 600115496 UDI# 05415067032003
Distribution
Part of a larger recall action
This product is one of 3 recalled by St. Jude Medical, Cardiac Rhythm Management Division under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · St. Jude Medical, Cardiac Rhythm Management Division
See all →- HighMerlin 2 PCS MER3400 programmer software recalled by St. Jude Medical
FDA (Devices) · 2022-08-10
- HighMerlin 2 PCS programming software for implantable devices recalled
FDA (Devices) · 2022-08-10
- HighPacemaker Programmer Software May Display Overestimated Battery Longevity
FDA (Devices) · 2022-08-10
- HighGallant VR Implantable Cardioverter Defibrillator Bluetooth malfunction impairs remote monitoring
FDA (Devices) · 2022-04-27
- HighGallant HF Implantable Cardioverter Defibrillator Bluetooth Malfunction Impairs Remote Monitoring
FDA (Devices) · 2022-04-27
Same hazard · bluetooth malfunction
See all →- HighAbbott Implantable Defibrillator Devices Recalled for Bluetooth Malfunction
FDA (Devices) · 2023-09-27
- HighAbbott Cardiac Defibrillators Recalled for Bluetooth Circuit Component Failure
FDA (Devices) · 2023-09-27
Similar recalls
- HighAbbott Cardiac Defibrillators Recalled for Bluetooth Circuit Component Failure
FDA (Devices) · 2023-09-27
- HighAbbott Implantable Defibrillator Devices Recalled for Bluetooth Malfunction
FDA (Devices) · 2023-09-27
- SevereImplantable cardioverter defibrillators may fail to deliver therapy
FDA (Devices) · 2023-06-28
- SevereImplantable Cardioverter Defibrillators May Fail to Deliver High-Voltage Therapy
FDA (Devices) · 2023-06-28
- SevereImplantable Defibrillators May Fail to Deliver High Voltage Therapy
FDA (Devices) · 2023-06-28
- HighMedtronic Cobalt DR MRI SureScan Defibrillators Recalled for Potential Loss of Function
FDA (Devices) · 2021-02-03